Retinal injections are primarily used when fluid leakage or abnormal blood vessel growth affects the macula, the part of the retina responsible for central vision. Patients often notice distortion, reduced sharpness, or difficulty recognising faces when macular involvement begins.
At Dr. Jyotis Hospital in Zirakpur, retinal injection therapy is considered for conditions such as diabetic macular edema and retinal vein occlusion, where vascular instability leads to swelling within retinal layers. The intent is to control disease activity and prevent further structural damage rather than produce immediate visual recovery.
Injection planning depends on OCT findings and measurable disease activity. Some patients respond after a limited number of injections, while others require extended treatment based on retinal thickness and fluid persistence. Decisions are driven by anatomical response rather than symptom fluctuation alone.
The procedure itself is brief and performed under local anaesthesia. Precision is essential, and post-injection assessment focuses on inflammation control, pressure stability, and retinal response to therapy.
If imaging shows active macular swelling or progressive vascular changes, targeted retinal injections may help limit further damage and preserve central vision.
